Advantage Trust Company’s Eli Lilly LLY Stock Holding History

Advantage Trust Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	865 +200	+30%	+$204K	0.37%	24
2026 Q1	$612K	Hold	665	–	–	0.27%	24
2025 Q4	$715K	Sell	665 -211	-24%	-$202K	0.32%	22
2025 Q3	$668K	Hold	876	–	–	0.3%	27
2025 Q2	$683K	Buy	876 +186	+27%	+$145K	0.34%	26
2025 Q1	$570K	Hold	690	–	–	0.35%	26
2024 Q4	$533K	Hold	690	–	–	0.31%	26
2024 Q3	$611K	Hold	690	–	–	0.42%	22
2024 Q2	$625K	Sell	690 -14	-2%	-$11.2K	0.45%	19
2024 Q1	$548K	Hold	704	–	–	0.4%	23
2023 Q4	$410K	Buy	+704	New	+$411K	0.32%	28

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Advantage Trust Company's LLY Position: Q2 2026 in Review

Advantage Trust Company increased its Eli Lilly (LLY) stake by 30% in Q2 2026, buying an estimated $204K and bringing the position to 865 shares worth $1.04M. The position accounts for 0.37% of the portfolio, ranked #24.

Advantage Trust Company first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Advantage Trust Company held 865 shares of Eli Lilly worth $1.04M as of Q2 2026.
Advantage Trust Company bought 200 Eli Lilly shares in Q2 2026, an estimated $204K.
Eli Lilly made up 0.37% of Advantage Trust Company's portfolio in Q2 2026, its #24 holding.
Advantage Trust Company first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.